BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Craanen ME, Blok P, Dekker W, Offerhaus GJ, Tytgat GN. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995;36:848-52. [PMID: 7615272 DOI: 10.1136/gut.36.6.848] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Kawachi H, Takizawa T, Eishi Y, Shimizu S, Kumagai J, Funata N, Koike M. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J Pathol. 2003;199:436-446. [PMID: 12635134 DOI: 10.1002/path.1323] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
2 Rocha FTR, Lourenço LG, Jucá MJ, Leal AT, Paz AMDCD. Expressão da proteína P53 no adenocarcinoma gástrico: correlação clínica, anatomopatológica e significância prognostica. Rev Col Bras Cir 2004;31:186-93. [DOI: 10.1590/s0100-69912004000300008] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Blok P, Craanen ME, Dekker W, Offerhaus GJA, Tytgat GNJ. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol 1998;186:36-40. [DOI: 10.1002/(sici)1096-9896(199809)186:1<36::aid-path150>3.0.co;2-r] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Seregni E, Ferrari L, Martinetti A, Bombardieri E. Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol 2001;20:147-66. [PMID: 11398208 DOI: 10.1002/ssu.1028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
5 Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis. J Pathol 1999;189:481-6. [PMID: 10629547 DOI: 10.1002/(SICI)1096-9896(199912)189:4<481::AID-PATH482>3.0.CO;2-U] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Meuwissen SG, Craanen ME, Kuipers EJ. Gastric mucosal morphological consequences of acid suppression: a balanced view.Best Pract Res Clin Gastroenterol. 2001;15:497-510. [PMID: 11403542 DOI: 10.1053/bega.2001.0189] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
7 Minematsu H, Saito Y, Kakinoki R, Andoh A, Kushima R, Fujiyama Y. Evaluation of mucin expression patterns in gastric borderline (group III) lesions. J Gastroenterol. 2006;41:547-553. [PMID: 16868802 DOI: 10.1007/s00535-006-1798-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
8 Craanen ME, Blok P, Top B, Boerrigter L, Dekker W, Offerhaus GJ, Tytgat GN, Rodenhuis S. Absence of ras gene mutations in early gastric carcinomas. Gut. 1995;37:758-762. [PMID: 8537044 DOI: 10.1136/gut.37.6.758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
9 Coffin CM, Hamilton MS, Pysher TJ, Bach P, Ashwood E, Schweiger J, Monahan D, Perry D, Rogers BB, Brugnara C, Rutledge J, Weiss R, Ash O, Hill H, Meikle W, Roberts W, Geaghan S. Pediatric laboratory medicine: current challenges and future opportunities. Am J Clin Pathol 2002;117:683-90. [PMID: 12090415 DOI: 10.1309/NYA1-V9KQ-NVF8-MA8M] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
10 Pinto-de-Sousa J, Silva F, David L, Leitão D, Seixas M, Pimenta A, Cardoso-de-Oliveira M. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma. Histopathology 2004;44:323-31. [PMID: 15049897 DOI: 10.1111/j.1365-2559.2004.01852.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
11 Nardone G, Staibano S, Rocco A, Mezza E, D'armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Figura N. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut. 1999;44:789-799. [PMID: 10323879 DOI: 10.1136/gut.44.6.789] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 4.2] [Reference Citation Analysis]
12 van Grieken NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, Lindeman J, Craanen ME, Bloemena E, Meuwissen SG, Baak JP, Kuipers EJ. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathol 2000;192:301-6. [PMID: 11054712 DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH697>3.0.CO;2-F] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
13 Roviello F, Marrelli D, Vindigni C, De Stefano A, Spina D, Pinto E. p53 Accumulation Is a Prognostic Factor in Intestinal-Type Gastric Carcinoma but Not in the Diffuse Type. Ann Surg Oncol 1999;6:739-45. [DOI: 10.1007/s10434-999-0739-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
14 Nardone G, Staibano S, Rocco A, Mezza E, Balzano T, Salvatore G, Staiano A, Donofrio V, Grazioli B, De Rosa G, Budillon G. Effect of Helicobacter pylori infection on gastric cell proliferation and genomic instablity in a paediatric population of Southern Italy. Digestive and Liver Disease 2001;33:743-9. [DOI: 10.1016/s1590-8658(01)80690-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Li Y, Sun Z, Zhu Z, Zhang J, Sun X, Xu H. PBX3 is overexpressed in gastric cancer and regulates cell proliferation. Tumour Biol. 2014;35:4363-4368. [PMID: 24375258 DOI: 10.1007/s13277-013-1573-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
16 Satoh K, Kihira K, Kawata H, Tokumaru K, Kumakura Y, Ishino Y, Kawakami S, Inoue K, Kojima T, Satoh Y, Mutoh H, Sugano K. p53 Expression in the Gastric Mucosa Before and After Eradication of Helicobacter pylori. Helicobacter 2001;6:31-6. [DOI: 10.1046/j.1523-5378.2001.00003.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
17 Coletta PL, Cartwright EJ, Markham AF. Transgenic models and cancer treatment. Cancer Treat Rev 1996;21:565-76. [PMID: 8599806 DOI: 10.1016/0305-7372(95)90019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
18 Ramus SJ, Bobrow LG, Pharoah PD, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BA, Friedman LS. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours. Genes Chromosomes Cancer 1999;25:91-6. [PMID: 10337991 DOI: 10.1002/(sici)1098-2264(199906)25:2<91::aid-gcc3>3.0.co;2-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
19 Oda T, Murakami K, Nishizono A, Kodama M, Nasu M, Fujioka T. Long-term Helicobacter pylori infection in Japanese monkeys induces atrophic gastritis and accumulation of mutations in the p53 tumor suppressor gene. Helicobacter. 2002;7:143-151. [PMID: 12047319 DOI: 10.1046/j.1523-5378.2002.00074.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
20 Graziano F, Cascinu S, Staccioli MP, Catalano V, Rossi MC, Baldelli AM, Giordani P, Muretto P, Catalano G. Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. BMC Cancer. 2001;1:9. [PMID: 11518545 DOI: 10.1186/1471-2407-1-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
21 Baas IO, van Rees BP, Musler A, Craanen ME, Tytgat GN, van den Berg FM, Offerhaus GJ. Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J Clin Pathol. 1998;51:662-666. [PMID: 9930069 DOI: 10.1136/jcp.51.9.662] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
22 Tamilzhalagan S, Muthuswami M, Ganesan K. Juxtaposed genes in 7q21-22 amplicon contribute for two major gastric cancer sub-Types by mutual exclusive expression: MUTUAL EXCLUSIVE EXPRESSION AMONG 7q21-22 GENES. Mol Carcinog 2017;56:1239-50. [DOI: 10.1002/mc.22586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
23 Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T, Satoh S, Yamaguchi T, Imamura H, Inoue M, Shiozaki H. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene. 2004;23:6830-6844. [PMID: 15273739 DOI: 10.1038/sj.onc.1207886] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
24 César ACG, Calmon MF, Cury PM, Caetano A, Borim AA, Silva AE. Genetic alterations in benign lesions: Chronic gastritis and gastric ulcer. World J Gastroenterol 2006; 12(4): 625-629 [PMID: 16489680 DOI: 10.3748/wjg.v12.i4.625] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
25 Isozaki H, Okajima K, Hu X, Fujii K, Sako S. Multiple early gastric carcinomas: Clinicopathologic features and histogenesis. Cancer 1996;78:2078-86. [DOI: 10.1002/(sici)1097-0142(19961115)78:10<2078::aid-cncr7>3.0.co;2-k] [Cited by in Crossref: 20] [Article Influence: 0.8] [Reference Citation Analysis]
26 Garcia SB, Park HS, Novelli M, Wright NA. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol 1999;187:61-81. [PMID: 10341707 DOI: 10.1002/(SICI)1096-9896(199901)187:1<61::AID-PATH247>3.0.CO;2-I] [Cited by in Crossref: 103] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
27 Ojima H, Fukuda T, Nakajima T, Nagamachi Y. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas. Jpn J Cancer Res. 1997;88:262-266. [PMID: 9140110 DOI: 10.1111/j.1349-7006.1997.tb00376.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
28 Kokkola A, Monni O, Puolakkainen P, Nordling S, Haapiainen R, Kivilaakso E, Knuutila S. Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. Cancer Genet Cytogenet. 1998;107:32-36. [PMID: 9809031 DOI: 10.1016/s0165-4608(98)00092-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
29 Kattoor J, Koriyama C, Akiba S, Itoh T, Ding S, Eizuru Y, Abraham EK, Chandralekha B, Amma N, Nair MK. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series. J Med Virol 2002;68:384-9. [DOI: 10.1002/jmv.10215] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
30 Schwerer MJ, Baczako K. Immunohistochemical evaluation of keratin 20 expression in intestinal metaplasia types I to III. J Clin Pathol 1996;49:791-4. [PMID: 8943741 DOI: 10.1136/jcp.49.10.791] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
31 Nishikawa J, Imai S, Oda T, Kojima T, Okita K, Takada K. Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol 1999;73:1286-92. [PMID: 9882333 DOI: 10.1128/JVI.73.2.1286-1292.1999] [Cited by in Crossref: 50] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
32 Blok P, Craanen ME, van Diest PJ, Dekker W, Tytgat GN. Lack of cyclin D1 overexpression in gastric carcinogenesis. Histopathology 2000;36:151-5. [PMID: 10672060 DOI: 10.1046/j.1365-2559.2000.00798.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
33 Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol. 1998;186:36-40. [PMID: 9875138 DOI: 10.1002/(SICI)1096-9896(199809)186:1%3C36::AID-PATH150%3E3.0.CO;2-R] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Yang J, Li C, Tang Y, Guo F, Chen Y, Luo W, Chen X, Ma Y, Zeng L. Diagnostic roles of proliferative markers in pathological Grade of T1 Urothelial Bladder Cancer. J Cancer 2021;12:2498-506. [PMID: 33854611 DOI: 10.7150/jca.52336] [Reference Citation Analysis]
35 Morales-Fuentes GA, Zarate-Osorno A, Quiñónez-Urrego EE, Antonio-Manrique M, Martínez-García CL, Figueroa-Barojas P, Zamorano-Orozco Y, Leal-Osuna SE, Martínez-Camacho C, Mejía-Cuán LA, Rivera-Nava CA, Sánchez-Chávez X, Ramírez-Ramírez MA. [p53 expression in the gastric mucosa of patients infected with Helicobacter pylori]. Rev Gastroenterol Mex 2013;78:12-20. [PMID: 23374541 DOI: 10.1016/j.rgmx.2012.11.001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
36 Kim JH, Shin HS, Lee SH, Lee I, Lee YS, Park JC, Kim YJ, Chung JB, Lee YC. Contrasting activity of Hedgehog and Wnt pathways according to gastric cancer cell differentiation: relevance of crosstalk mechanisms. Cancer Sci 2010;101:328-35. [PMID: 19930158 DOI: 10.1111/j.1349-7006.2009.01395.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
37 Ishibashi M, Kogo R, Shibata K, Ueo H, Uchi R, Matsumura T, Takano Y, Sawada G, Takahashi Y, Mima K, Kurashige J, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Suzuki A, Wakabayashi G, Mori M, Mimori K. Clinical Significance of PICT1 in Patients of Hepatocellular Carcinoma with Wild-Type TP53. Ann Surg Oncol 2013;20:537-44. [DOI: 10.1245/s10434-013-2958-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat. 2003;21:258-270. [PMID: 12619111 DOI: 10.1002/humu.10180] [Cited by in Crossref: 160] [Cited by in F6Publishing: 139] [Article Influence: 8.9] [Reference Citation Analysis]
39 Jin Z, Tamura G, Honda T, Motoyama T. Molecular and Cellular Phenotypic Profiles of Gastric Noninvasive Neoplasia. Lab Invest 2002;82:1637-45. [DOI: 10.1097/01.lab.0000041712.58604.cc] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
40 Petersson F, Borch K, Franzén LE. Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection. Dig Dis Sci 2002;47:1558-66. [PMID: 12141817 DOI: 10.1023/a:1015938303993] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
41 Colucci*, C. Mothersill, J. Harney, S. Induction of multiple PCR-SSCPE mobility shifts in exons in cultures of normal human urothelium exposed to low-dose gamma radiation. International Journal of Radiation Biology 2009;72:21-31. [DOI: 10.1080/095530097143509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Strauss BS. Hypermutability in Carcinogenesis. Genetics 1998;148:1619-26. [DOI: 10.1093/genetics/148.4.1619] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
43 Lacueva FJ, Calpena R, Medrano J, Teruel A, Mayol MJ, Graells ML, Camarasa MV, Perez-vazquez MT, Ferragut JA. Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. Cancer 2000;89:21-8. [DOI: 10.1002/1097-0142(20000701)89:1<21::aid-cncr4>3.0.co;2-t] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
44 Lacueva FJ, Calpena R, Medrano J, Teruel A, Mayol MJ, Graells ML, Camarasa MV, Perez-Vazquez MT, Ferragut JA. Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. Cancer. 2000;89:21-28. [PMID: 10896996 DOI: 10.1002/1097-0142(20000701)89:1%3C21::AID-CNCR4%3E3.0.CO;2-T] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Lee HS, Lee HK, Kim HS, Yang H, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003;200:39-46. [DOI: 10.1002/path.1288] [Cited by in Crossref: 126] [Cited by in F6Publishing: 126] [Article Influence: 7.0] [Reference Citation Analysis]